MedTrace Logo

Treatment of Pilonidal Sinus Disease Using Surgiflo as a Sealant: A New Concept

NCT02638064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-12-22

No results posted yet for this study

Summary

Assessment of surgiflo injection for treating pilonidal sinus disease

Conditions

  • Pilonidal Sinus Disorder

Interventions

PROCEDURE

Surgiflo injection

Curettage of sinus cavity then injection of surgiflo material

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Hosam Elbanna, M.D · private basis

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-03-31
Completion
2015-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02638064 on ClinicalTrials.gov